Presentation TCT 2021 Pascal EFS, EU Registry, and Compassionate Use Outcomes Presenter: Charles J. Davidson November 04, 2021 REGISTER for free or LOG IN to view this content Structural Heart Tricuspid Valve Presentation TCT 2021 TEER Up Next Presentation TCT 2021 Pascal EFS, EU Registry, and Compassionate Use Outcomes Presenter: Charles Davidson November 04, 2021 More slides + Presentation TCT 2021 TCT 540: LAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI Presenter: Michael Chiang November 04, 2021 Presentation TCT 2021 Who Is the Ideal Candidate for TEER? Clinical and Anatomical Considerations Presenter: Jason Rogers November 04, 2021 We Recommend
Presentation TCT 2021 Pascal EFS, EU Registry, and Compassionate Use Outcomes Presenter: Charles Davidson November 04, 2021
Presentation TCT 2021 TCT 540: LAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI Presenter: Michael Chiang November 04, 2021
Presentation TCT 2021 Who Is the Ideal Candidate for TEER? Clinical and Anatomical Considerations Presenter: Jason Rogers November 04, 2021